Meihua International Medical Technologies changes independent auditor

Meihua International Medical Technologies Co., Ltd. reported a change in its independent auditor.

Accepted by SEC EDGAR 01/07/2026 - 04:05 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Meihua International Medical Technologies Co., Ltd. reported a change in its independent auditor. Effective December 26, 2025, the board and audit committee dismissed Kreit & Chiu CPA LLP and appointed Li CPA LLC (PCAOB ID: 7093) as the company’s independent registered public accounting firm for the year ended December 31, 2025.

The company states that Kreit & Chiu CPA’s audit reports for 2022, 2023, and 2024 contained no adverse opinions, disclaimers, or qualifications and that there were no disagreements or reportable events under SEC rules during those periods. Meihua also notes it did not previously consult Li CPA on accounting or auditing matters before this engagement. A confirming letter from Kreit & Chiu CPA has been filed as an exhibit.

Insights

Audit & governance analyst

Routine auditor change disclosed with no reported disputes or issues.

Meihua International Medical Technologies has replaced Kreit & Chiu CPA LLP with Li CPA LLC as its independent registered public accounting firm for the year ended December 31, 2025. The decision was approved by the board of directors and the audit committee, which is standard governance practice for auditor appointments.

The company states that prior audit reports from Kreit & Chiu CPA for 2022–2024 had no adverse or qualified opinions and that there were no disagreements or reportable events as defined in Regulation S-K. This language aims to indicate that the change is not being driven by disclosed accounting disputes.

The disclosure also notes that the company did not consult Li CPA on specific accounting or audit opinions before the engagement, which addresses independence and selection considerations. A letter from Kreit & Chiu CPA to the SEC, filed as Exhibit 16.1 and dated January 7, 2026, is intended to confirm its agreement with the company’s description of the relationship.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What change did Meihua International Medical Technologies (MHUA) report in this 6-K?

The company reported that it dismissed Kreit & Chiu CPA LLP as its independent registered public accounting firm and appointed Li CPA LLC to audit its financial statements for the year ended December 31, 2025.

Were there any disagreements between MHUA and its former auditor Kreit & Chiu CPA LLP?

The company states there were no disagreements with Kreit & Chiu CPA on accounting principles, financial statement disclosure, or audit scope or procedures during the two most recent fiscal years ended December 31, 2024, and that there were no reportable events under SEC rules.

How did MHUA describe the prior audit opinions from Kreit & Chiu CPA LLP?

Meihua reports that Kreit & Chiu CPA’s audit reports on its financial statements for 2022, 2023, and 2024 did not contain adverse opinions, disclaimers of opinion, or qualifications related to uncertainty, audit scope, or accounting principles.

Did Meihua International consult Li CPA LLC before engaging it as auditor?

The company states that during the two most recent fiscal years and subsequent interim periods before engaging Li CPA LLC, neither it nor anyone on its behalf consulted Li CPA on the application of accounting principles or on any matters involving disagreements or reportable events.

What document did Kreit & Chiu CPA LLP provide regarding the MHUA auditor change?

Kreit & Chiu CPA provided a letter to the U.S. Securities and Exchange Commission addressing whether it agrees with the company’s statements, and this letter is filed as Exhibit 16.1 dated January 7, 2026.

Who signed the MHUA Form 6-K related to the auditor change?

The report was signed on behalf of Meihua International Medical Technologies Co., Ltd. by Leyi Lee, the company’s Chief Executive Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the Month of January 2026

Commission file number 001-41291

Meihua International Medical Technologies Co., Ltd.

(Translation of registrant’s name into English)

88 Tongda Road, Touqiao Town

Guangling District, Yangzhou, 225000

People’s Republic of China

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒     Form 40-F  ☐

Change of Auditor

On December 26, 2025, Meihua International Medical Technologies Co., Ltd. (the “Company”), upon the approval of the board of directors of the Company (the “Board”) and the audit committee of the Board (the “Audit Committee”), dismissed Kreit & Chiu CPA LLP (“Kreit & Chiu CPA”), the former independent registered public accounting firm of the Company and appointed Li CPA LLC (PCAOB ID: 7093) (“Li CPA”) to serve as its independent registered public accounting firm for the year ended December 31, 2025.

Kreit & Chiu CPA’s reports on the Company’s financial statements for the fiscal year ended December 31, 2024, 2023, and 2022 did not contain an adverse opinion or a disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles. Furthermore, during the Company’s two most recent fiscal years ended December 31, 2024, there were no disagreements with Kreit & Chiu CPA on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Kreit & Chiu CPA, would have caused Kreit & Chiu CPA to make reference to the subject matter of the disagreements in connection with its reports on the Company’s financial statements for such year. Also, during this time, there were no “reportable events,” as defined in Item 304(a)(1)(v) of Regulation S-K.

The Company provided Kreit & Chiu CPA with a copy of the above disclosure and requested that Kreit & Chiu CPA furnish the Company with a letter addressed to the U.S. Securities and Exchange Commission stating whether or not it agrees with the above statements. A copy of the Kreit & Chiu CPA’s letter is filed as Exhibit 16.1 to this Form 6-K.

During the two most recent fiscal years and any subsequent interim periods prior to the engagement of Li CPA, neither the Company, nor someone on behalf of the Company, has consulted Li CPA regarding (i) the application of accounting principles to any specified transaction, either completed or proposed or the type of audit opinion that might be rendered on the Company’s consolidated financial statements, and neither a written report nor oral advice was provided to the Company that Li CPA concluded was an important factor considered by the Company in reaching a decision as to any accounting, auditing, or financial reporting issue, or (ii) any matter that was either the subject of a “disagreement,” as defined in Item 304(a)(1)(iv) of Regulation S-K, or a “reportable event,” as defined in Item 304(a)(1)(v) of Regulation S-K, or any other matters set forth in Item 304(a)(2)(i) and (ii) of Regulation S-K .

Financial Statements and Exhibits.

Exhibit No.		Description
16.1		Letter from Kreit & Chiu CPA to the U.S. Securities and Exchange Commission dated January 7, 2026

1 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Meihua International Medical Technologies Co., Ltd.
By:	/s/ Leyi Lee
Name:	Leyi Lee
Title:	Chief Executive Officer
Date: January 7, 2026

2